Professional Documents
Culture Documents
1900-
Karl Landsteiner
300
AIMO
SLIDE TEST
, zeta-potential
10
/
.
11
PH
6,5-7,5
..
anti-M
12
24 4
IGM
13
14
IgM
ABH, MN,Lewis,Lutheran
a
IgG
Ss, Kell, Rh(DCEce),
Lutheran b, Duffy Kidd
15
zeta-potential
polybrene
16
Rhesus,Kidd,Lewis,P1,I,ABO
Duffy,MNS,Xga
17
zeta-potential
22% Bovine Serum Albumin
Rhesus
18
POLYBRENE
()
.
-Kell
19
.
POLYETHYLENEGLYCOLE (PEG)
,
antiIgG .
.
37
20
LISS
,
21
TEST TUBE
22
-1
SCORE
10
4+
10
3+
2+
1+
23
-2
+w
+/- m
m+
Mf
Mixed-field
NA
rouleaux
NA
24
25
M. Zaharna Practical Blood Bank 2009
26
27
M. Zaharna Practical Blood Bank 2009
COLUMN TECHNIQUE
28
29
G,antiIgM,C3d
30
405 nm
IgG
31
-1
37
IgG
32
-2
33
Plasma
Liss
100 l of
Capture LISS
Red Blood
Cells
50 l of
donor/patient
plasma
or
Anti-Sera if weak D
test or rare antigen
typing is required
34
Incubation
Incubate test strips for
10 to 30 minutes.
Depends on the test
running
(60 minutes max)
35
36
Indicator Cell
Capture-R Ready Indicator Red
Cell
Anti-D
Group O Rh positive
Human Red Blood
Cell
RBC
Anti-IgG
37
600g
ramp up 135
38
Final Read
39
40
-IgG ANTI-C3d
:
(anti-Jka)
:
41
AHG
ANTI-IgG
ANTI-Complement (C3b+C3d /C3d)
42
ANTIGLOBULIN
TEST/COOMBS TEST
Moreshi 1908
Coombs 1945
IGG
,IGG
43
COOMBS-1
in vivo
IgG /
.
1.
2.
3.
4.
44
COOMBS-2
3-5%
3
AHG
45
46
DAT
-
PEG
rouleaux
47
COOMBS ()
48
35%
2-3
37
(15-60min)
3
2
49
50
COOMBS CONTROL
51
(,)
PEG
DAT ,
52
53
TEST
200-500
IgG C3
DAT
IAT 100-200 IgG
C3
54
55
(,
)
56
panel
11-20
.
Rh , Duffy, Kidd
MNS
profile
57
Antibody panel
panel
11
58
rule out
(K,Kpa,Jsa,Lua)
59
STEP BY STEP
60
o
?
(I,P1,Lea,Leb,Vel,Ch/Rg,Sda)
61
?
-
(gM/IgG)
62
63
I
CONTROL
?
64
65
RULE OF THREE
3
3 3
p<0.05
95%
panels
3
66
LANDSTEINER
67
Panel
68
Panel
panels
autocontrol
69
Panel
antibody screening
70
71
IS(IMMEDIATE SPIN)
72
73
74
75
.
check cells
AHG!!!
76
77
78
1.
-
79
2.
80
3.
81
4. ;
! !!!!!
82
83
rule of three
84
MHN
Papain, bromelin,
ficin, and trypsin
Kidd
Rh
Lewis
I
P
Fya and
Fyb
M, N
S, s
85
Anti-Kell
86
DAT
Y
Y
Positive DAT
Sensitized
RBC
Elution
Frees antibody
Antibody ID
87
o
DAT
HDN, ,
panel.
88
:
30min 2h
.
.
DAT
(acid glycine/EDTA)
O (,)
-
89
-
.
.
90
-1
-
-
-
-
91
-2
92
R1R1
(DCee),R2R2(DcEE0,rr(ccee)
Kell-,
Jka- Jkb
93
Remove
serum and
test for
alloantibody
2
tubes
Wash x3 after
incubation
Centrifuge after
incubating; and transfer
serum to 2nd tube of
treated cells; incubate
and centrifuge again
94
95
g ,
96
TEST
. ,
, .
,
Lewis,P1,Sd
97
P1 INHIBITION TESTS
1
,
99
Sda INHIPITION
Sda
100
-1
Ag
score
101
SCORE ANTI-D
1:2
1:4
1:8
1:16
2+
2+
1+
8
3+
8
3+
10
10
1:32
1:64
1:128
W+ 0
16
5
2+
2
2+
0
1+
0
0
W+ 0
23
64
43
SCORE
SCORE
TIT-2
score 10
.
103
,
104
HTLA
H
LA (high titer,low
avidity)
,
. 1/2048
anti-Ch, -Rg, -Cs, -Yk, -Kna, -McCa and -JMH.
105
ull phenotypes .
Rh null, Ko, Co (a-b-), Lu (a-b-),
Fy (a-b-), Jk(a-b-).
,
panel.
Western blotting /
106
107
-HTLA
AN
108
109
PCR-RFLP
PCR-SSP
Multiplex PCR
RT-PCR
Sanger DNA Sequencing
Pyrosequensing
Microarray technology
Fluidic microarray system
TaqMan Open Array
MALDI-TOF MS
Mini-sequencing
110
111
112
113
Rhesus D positive
CcD.ee Kell positive
114
115
Microwell-agglutination strength 1
116
117
Weak D
118
Rhesus D negative
Ccee Kell negative
119
120
Microwell plate-negative
121
122
123
D VI II
Rhesus
Rhesus
124
125
126
127